Nuveen Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$24.7M Sell
1,347,093
-15,892
-1% -$292K 0.01% 1035
2024
Q3
$21M Buy
1,362,985
+921,136
+208% +$14.2M 0.01% 1159
2024
Q2
$7.18M Buy
441,849
+3,971
+0.9% +$64.5K ﹤0.01% 1765
2024
Q1
$8.1M Buy
437,878
+20,806
+5% +$385K ﹤0.01% 1733
2023
Q4
$13.1M Sell
417,072
-34,230
-8% -$1.07M ﹤0.01% 1418
2023
Q3
$9.41M Sell
451,302
-239,664
-35% -$4.99M ﹤0.01% 1513
2023
Q2
$16.5M Buy
690,966
+169,717
+33% +$4.06M 0.01% 1191
2023
Q1
$9.81M Buy
521,249
+21,172
+4% +$398K ﹤0.01% 1493
2022
Q4
$7.96M Sell
500,077
-428,896
-46% -$6.83M ﹤0.01% 1637
2022
Q3
$15.2M Sell
928,973
-167,229
-15% -$2.74M 0.01% 1202
2022
Q2
$15.4M Buy
1,096,202
+214,314
+24% +$3.02M 0.01% 1234
2022
Q1
$22.5M Buy
881,888
+287,607
+48% +$7.35M 0.01% 1129
2021
Q4
$13.2M Buy
594,281
+48,585
+9% +$1.08M ﹤0.01% 1524
2021
Q3
$9.11M Sell
545,696
-440,806
-45% -$7.36M ﹤0.01% 1842
2021
Q2
$24.1M Sell
986,502
-442,485
-31% -$10.8M 0.01% 1218
2021
Q1
$36.9M Sell
1,428,987
-27,570
-2% -$711K 0.01% 901
2020
Q4
$77.9M Sell
1,456,557
-125,722
-8% -$6.72M 0.03% 511
2020
Q3
$65.3M Buy
1,582,279
+344,846
+28% +$14.2M 0.03% 484
2020
Q2
$60M Sell
1,237,433
-768,311
-38% -$37.2M 0.02% 503
2020
Q1
$84.7M Sell
2,005,744
-191,174
-9% -$8.08M 0.04% 344
2019
Q4
$94M Buy
2,196,918
+642,321
+41% +$27.5M 0.04% 426
2019
Q3
$56M Sell
1,554,597
-33,306
-2% -$1.2M 0.02% 602
2019
Q2
$42.4M Buy
+1,587,903
New +$42.4M 0.02% 764
2016
Q1
Sell
-28,473
Closed -$1.02K 1371
2015
Q4
$1.02K Sell
28,473
-3,292
-10% -$117 0.01% 1037
2015
Q3
$1.05K Sell
31,765
-590
-2% -$20 0.01% 1024
2015
Q2
$1.36K Buy
+32,355
New +$1.36K 0.01% 984
2014
Q2
Sell
-44,723
Closed -$1.09M 1539
2014
Q1
$1.09M Sell
44,723
-3,797
-8% -$92.4K 0.01% 1045
2013
Q4
$1.21M Buy
+48,520
New +$1.21M 0.01% 945